vimarsana.com

Latest Breaking News On - Satwinder kaur singh - Page 1 : vimarsana.com

Mendus to present novel data supporting the broad potential of its proprietary cancer vaccine platform at CICON23

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, will present novel clinical and preclinical data on the mode of action of its lead clinical program.

United statesCorey davisJorn kaspersHans nijmanAlex karlsson parraHaoxiao zuoMario brkuljErik mantingGerty schreibeltSatwinder kaur singhAmerican society of hematologyLifesci advisorsRadboud institute for molecular life sciencesDepartment of tumor immunologyValency communicationsRadboud university medical centre

Immunicum AB: Immunicum to Present Preclinical Data Demonstrating Synergy of DCP-001 with Standard Treatments for Acute Myeloid Leukemia

COMBINATION OF CANCER RELAPSE VACCINE CANDIDATE WITH 5'-AZACITIDINE AND VENETOCLAX SHOWS SUPERIOR TUMOR REDUCTION IN AN AML MODEL Immunicum AB ("Immunicum" publ; IMMU.ST), a biopharmaceutical

Julie seidelMario brkuljErik mantingAlex karlsson parraSatwinder kaur singhResearch at immunicumValency communicationsAnnual meetingChief scientific officerDirector research

Investegate |Immunicum AB Announcements | Immunicum AB: Immunicum to Participate in Upcoming Investor and Industry Conferences in January

Investegate announcements from Immunicum AB, Immunicum to Participate in Upcoming Investor and Industry Conferences in January

Satwinder kaur singhErik mantingEva mulderHc wainwright bioconnectSophia hergenhanKristina windrup olanderBrendan payneResearch at immunicumTrophic communicationsUpcoming investorIndustry conferencesBioconnect virtual conferenceChief executive officerClient eventCell therapies summit europeDigital event

Immunicum AB: Immunicum to Participate in Upcoming Investor and Industry Conferences in January

Press Release Stockholm, Sweden, January 3, 2022 Immunicum to Participate in Upcoming Investor and Industry Conferences in January Immunicum AB ("Immunicum" publ; IMMU.ST), a biopharmaceutical

Satwinder kaur singhErik mantingEva mulderHc wainwright bioconnectSophia hergenhanKristina windrup olanderBrendan payneResearch at immunicumTrophic communicationsUpcoming investorIndustry conferencesBioconnect virtual conferenceChief executive officerClient eventCell therapies summit europeDigital event

Immunicum AB: Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November

Press Release 01 November 2021 Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November Immunicum AB (publ) today announced that it will participate

United statesCity ofUnited kingdomNoord hollandEva mulder sophia hergenhanErik mantingAlex karlsson parraSatwinder kaur singhKristina windrup olanderSociety for immunotherapy of cancerTrophic communicationsMultiple upcoming industryInvestor eventsChief executive officerAnnual meetingKaur singh

vimarsana © 2020. All Rights Reserved.